EvoBiotech uses the power of plant-derived extracellular vesicle to create a new generation of advanced therapies for wound care.
We have created an innovative safe, affordable and efficient platform based on extracellular vesicles to develop new therapies applied to regenerative medicine for wound lesions treatment. Our solution addresses all-in-one the scientific, medical and social concerns of wounds, improving the patient outcomes.
We exploit the extraordinary regenerative properties of extracellular vesicles, a new emerging technology that represent the next generation of medicine.
Extracellular vesicles are released by all kind of cells.
They are bioactive nanoparticles composed by lipids, proteins, and nucleic acids. They transfer information from donor cell to the recipient cell, activate regenerative programs, and promote tissue regeneration.
Extracellular vesicles are a new emerging technology.
EvoBiotech submitted a patent to the Italian Patent Office.